Cite
MLA Citation
Brian M. Wolpin et al.. “Multicenter Phase II Study of Tivozanib (AV‐951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.” Oncologist, vol. 18, 2013, pp. 377–378. http://access.bl.uk/ark:/81055/vdc_100054358897.0x00002f